Literature DB >> 2506920

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

P A de Bruin1, H W Verspaget, G Griffioen, J H Verheijen, G Dooijewaard, C B Lamers.   

Abstract

In resection tissue samples of colorectal carcinomas, the concentration of urokinase-type plasminogen activator (u-Pa) was found to be significantly higher than in the normal parent mucosal tissue, while there was less tissue-type plasminogen activator (t-PA). u-PA and t-PA were also determined in endoscopic biopsies of colonic and gastric carcinomas, and the results were compared with those of the ultimate resection samples of the same patients, and with the histological evaluation of adjacent biopsies. The ratio of u-PA/t-PA antigen in the biopsies was found to represent a good discriminator between normal and malignant tissue. Nearly all (90%) tumour biopsies had a higher PA antigen ratio than that of the normal tissue biopsies. This discrimination based upon PA antigen measurements in biopsies was similarly efficient in the subsequent resection samples, and showed a good agreement with the histological evaluation. Thus, PA antigen measurements in endoscopic biopsies can be used to detect gastrointestinal malignancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506920      PMCID: PMC2247195          DOI: 10.1038/bjc.1989.293

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

2.  Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis.

Authors:  W Dekker; G N Tytgat
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

Review 3.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

4.  Quantitation of urokinase antigen in plasma and culture media by use of an ELISA.

Authors:  D J Binnema; J J van Iersel; G Dooijewaard
Journal:  Thromb Res       Date:  1986-09-01       Impact factor: 3.944

5.  Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas.

Authors:  J C Kirchheimer; K Huber; O Wagner; B R Binder
Journal:  Br J Haematol       Date:  1987-05       Impact factor: 6.998

6.  Plasminogen activator profiles in neoplastic tissues of the human colon.

Authors:  P A de Bruin; G Griffioen; H W Verspaget; J H Verheijen; G Dooijewaard; H F van den Ingh; C B Lamers
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

7.  Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.

Authors:  P A de Bruin; G Griffioen; H W Verspaget; J H Verheijen; C B Lamers
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

Review 8.  Plasminogen activator and cancer.

Authors:  M J Duffy; P O'Grady
Journal:  Eur J Cancer Clin Oncol       Date:  1984-05

9.  The urokinase type of plasminogen activator in cancer of digestive tracts.

Authors:  N Nishino; K Aoki; Y Tokura; S Sakaguchi; Y Takada; A Takada
Journal:  Thromb Res       Date:  1988-05-15       Impact factor: 3.944

10.  Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay.

Authors:  D C Rijken; V W van Hinsbergh; E H Sens
Journal:  Thromb Res       Date:  1984-01-15       Impact factor: 3.944

View more
  2 in total

1.  Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

Authors:  D Samid; S Shack; C E Myers
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

Authors:  C F Sier; H W Verspaget; G Griffioen; S Ganesh; H J Vloedgraven; C B Lamers
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.